New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
DPA International on MSN
Global life expectancy rebounds to pre-pandemic levels, study finds
Global life expectancy returned in 2023 to levels seen before the Covid-19 pandemic, rising to 76. 3 years for women and 71.
NEW YORK (Reuters Health) - Worldwide, chronic obstructive pulmonary diseases are damaging the confidence, and the incomes, of an increasing number of patients still of working age, a new ...
Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...
Company reiterates its precision prevention commitment with latest expansion of its high-stakes cancer pledge—now targeting lung cancer, the world's deadliest cancer. Whole genome sequencing with ...
MIAMI, Sept. 17, 2025 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company dedicated to "Treating Diseases of Aging and Treating Aging as Disease™," today announced the appointment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback